Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)
Chih Yi Lin, Chung Jen Yu, Chun Yu Liu, Ta Chung Chao, Chi Cheng Huang, Ling Ming Tseng, Jiun I. Lai*
Research output: Contribution to journal › Comment/debate
Fingerprint
Dive into the research topics of 'Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)'. Together they form a unique fingerprint.